Publication:
CIRCULATING MIR-132, MIR-146A, MIR-222, AND MIR-320 EXPRESSION IN DIFFERENTIAL DIAGNOSIS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME

dc.contributor.authorSoyman, Z.
dc.contributor.authorDurmus, S.
dc.contributor.authorAtes, S.
dc.contributor.authorSimsek, G.
dc.contributor.authorSozer, V
dc.contributor.authorKundaktepe, B. P.
dc.contributor.authorKurtulus, D.
dc.contributor.authorGelisgen, R.
dc.contributor.authorSal, V
dc.contributor.authorUzun, H.
dc.date.accessioned2022-09-27T20:59:10Z
dc.date.available2022-09-27T20:59:10Z
dc.date.issued2022-01-01T00:00:00Z
dc.description.abstractPurpose: The aim of the study was to investigate whether the circulating miR-132, miR-146a, miR-222, and miR-320 levels are used in the differential diagnosis of women with polycystic ovary syndrome (PCOS) and healthy women. Methods: This prospective case-control study included 50 women with PCOS and age- and body mass index- matched 50 healthy controls. The hormone and lipid profiles, levels of microRNAs (miRNAs), and parameters of carbohydrate metabolism were measured. Results: Expression levels of miRNAs were assessed using the two-step quantitative real-time polymerase chain reaction. Circulating miR-132, miR-146a and miR-222 levels were significantly downregulated in the PCOS group compared with the control group. The miR-320 levels did not differ between the two groups. Free testosterone was negatively correlated with miR-132, miR-146a and miR-222. Insulin was negatively correlated with miR-132 and miR-146a. Conclusions: The results of the study revealed that miRNA expression, may suggest a possible distinction between healthy women and PCOS patients. miR-132, miR-146a, and miR-222 may have key functions in the pathogenesis of PCOS.
dc.identifier.citationSoyman Z., Durmus S., Ates S., Simsek G., Sozer V., Kundaktepe B. P. , Kurtulus D., Gelisgen R., Sal V., Uzun H., -CIRCULATING MIR-132, MIR-146A, MIR-222, AND MIR-320 EXPRESSION IN DIFFERENTIAL DIAGNOSIS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME-, ACTA ENDOCRINOLOGICA-BUCHAREST, cilt.18, sa.1, ss.13-19, 2022
dc.identifier.doi10.4183/aeb.2022.13
dc.identifier.pubmed35975247
dc.identifier.scopus85135579887
dc.identifier.urihttp://hdl.handle.net/20.500.12645/31030
dc.identifier.wosWOS:000850761500002
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPolycystic ovary syndrome
dc.subjectmiR-132
dc.subjectmiR-146a
dc.subjectmiR-222
dc.titleCIRCULATING MIR-132, MIR-146A, MIR-222, AND MIR-320 EXPRESSION IN DIFFERENTIAL DIAGNOSIS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME
dc.typeArticle
dspace.entity.typePublication
local.avesis.ida72eeb86-dc29-4c77-bc5f-91f56e7175cd
local.publication.isinternational1

Files